Wellington Management Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-70,778
| Closed | -$6.02M | – | 2067 |
|
|
2020
Q3 | $6.02M | Buy |
+70,778
| New | +$3.58M | ﹤0.01% | 1228 |
|
|
2020
Q1 | – | Sell |
-63,707
| Closed | -$1.35M | – | 2128 |
|
|
2019
Q4 | $1.35M | Buy |
+63,707
| New | +$1.12M | ﹤0.01% | 1639 |
|
|
2019
Q3 | – | Sell |
-28,415
| Closed | -$394K | – | 2162 |
|
|
2019
Q2 | $394K | Hold |
28,415
| – | – | ﹤0.01% | 1941 |
|
|
2019
Q1 | $546K | Buy |
+28,415
| New | +$458K | ﹤0.01% | 1887 |
|
|
2018
Q1 | – | Sell |
-68,177
| Closed | -$1.1M | – | 2382 |
|
|
2017
Q4 | $1.1M | Sell |
68,177
-83,170
| -55% | -$982K | ﹤0.01% | 1876 |
|
|
2017
Q3 | $2.12M | Buy |
+151,347
| New | +$1.51M | ﹤0.01% | 1708 |
|
|
2014
Q2 | – | Sell |
-188,470
| Closed | -$793K | – | 2268 |
|
|
2014
Q1 | $793K | Sell |
188,470
-204,448
| -52% | -$1.01M | ﹤0.01% | 1880 |
|
|
2013
Q4 | $1.81M | Buy |
392,918
+271,518
| +224% | +$1.21M | ﹤0.01% | 1723 |
|
|
2013
Q3 | $751K | Buy |
+121,400
| New | +$699K | ﹤0.01% | 1868 |
|
Wellington Management Group's IMMU Position: Q4 2020 in Review
Wellington Management Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 70,778 shares — an estimated $6.02M sold.
Wellington Management Group first reported a position in IMMU in Q3 2013 and held it in 9 quarters. The position peaked at $6.02M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Wellington Management Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Wellington Management Group sold 70,778 Immunomedics Inc shares in Q4 2020, an estimated $6.02M.
- Wellington Management Group first reported a position in Immunomedics Inc in Q3 2013 and held it in 9 quarters.
- Wellington Management Group's Immunomedics Inc position peaked at $6.02M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Wellington Management Group's 13F filing for Q4 2020, filed 12 Feb 2021.